nodes	percent_of_prediction	percent_of_DWPC	metapath
Rizatriptan—migraine—Prednisone—hematologic cancer	0.475	1	CpDpCtD
Rizatriptan—CYP1A2—Anagrelide—hematologic cancer	0.0516	0.217	CbGbCtD
Rizatriptan—CYP1A2—Carmustine—hematologic cancer	0.0271	0.114	CbGbCtD
Rizatriptan—CYP1A2—Methoxsalen—hematologic cancer	0.0231	0.0969	CbGbCtD
Rizatriptan—CYP1A2—Bortezomib—hematologic cancer	0.0219	0.0922	CbGbCtD
Rizatriptan—CYP1A2—Daunorubicin—hematologic cancer	0.021	0.0882	CbGbCtD
Rizatriptan—CYP1A2—Alitretinoin—hematologic cancer	0.0205	0.0864	CbGbCtD
Rizatriptan—CYP1A2—Thalidomide—hematologic cancer	0.0191	0.0803	CbGbCtD
Rizatriptan—CYP1A2—Dacarbazine—hematologic cancer	0.0164	0.0691	CbGbCtD
Rizatriptan—CYP1A2—Imatinib—hematologic cancer	0.0161	0.0676	CbGbCtD
Rizatriptan—CYP1A2—Dasatinib—hematologic cancer	0.0129	0.0543	CbGbCtD
Rizatriptan—CYP1A2—Etoposide—hematologic cancer	0.00804	0.0338	CbGbCtD
Rizatriptan—Melatonin—CALR—hematologic cancer	0.00211	0.607	CrCbGaD
Rizatriptan—Sumatriptan—ABCG2—hematologic cancer	0.000452	0.13	CrCbGaD
Rizatriptan—Melatonin—MPO—hematologic cancer	0.000415	0.119	CrCbGaD
Rizatriptan—Melatonin—ESR1—hematologic cancer	0.000311	0.0894	CrCbGaD
Rizatriptan—Sumatriptan—ABCB1—hematologic cancer	0.000188	0.0542	CrCbGaD
Rizatriptan—Angiopathy—Epirubicin—hematologic cancer	2.78e-05	0.00012	CcSEcCtD
Rizatriptan—Decreased appetite—Dexamethasone—hematologic cancer	2.78e-05	0.000119	CcSEcCtD
Rizatriptan—Decreased appetite—Betamethasone—hematologic cancer	2.78e-05	0.000119	CcSEcCtD
Rizatriptan—Nausea—Mitoxantrone—hematologic cancer	2.77e-05	0.000119	CcSEcCtD
Rizatriptan—Nausea—Irinotecan—hematologic cancer	2.77e-05	0.000119	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Betamethasone—hematologic cancer	2.76e-05	0.000119	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Dexamethasone—hematologic cancer	2.76e-05	0.000119	CcSEcCtD
Rizatriptan—Fatigue—Betamethasone—hematologic cancer	2.76e-05	0.000119	CcSEcCtD
Rizatriptan—Fatigue—Dexamethasone—hematologic cancer	2.76e-05	0.000119	CcSEcCtD
Rizatriptan—Chills—Epirubicin—hematologic cancer	2.75e-05	0.000118	CcSEcCtD
Rizatriptan—Pruritus—Etoposide—hematologic cancer	2.75e-05	0.000118	CcSEcCtD
Rizatriptan—Shock—Prednisone—hematologic cancer	2.74e-05	0.000118	CcSEcCtD
Rizatriptan—Arrhythmia—Epirubicin—hematologic cancer	2.74e-05	0.000118	CcSEcCtD
Rizatriptan—Pain—Betamethasone—hematologic cancer	2.73e-05	0.000118	CcSEcCtD
Rizatriptan—Pain—Dexamethasone—hematologic cancer	2.73e-05	0.000118	CcSEcCtD
Rizatriptan—Nervous system disorder—Prednisone—hematologic cancer	2.73e-05	0.000117	CcSEcCtD
Rizatriptan—Tachycardia—Prednisone—hematologic cancer	2.72e-05	0.000117	CcSEcCtD
Rizatriptan—Nausea—Gemcitabine—hematologic cancer	2.7e-05	0.000116	CcSEcCtD
Rizatriptan—Vomiting—Cisplatin—hematologic cancer	2.7e-05	0.000116	CcSEcCtD
Rizatriptan—Hyperhidrosis—Prednisone—hematologic cancer	2.69e-05	0.000116	CcSEcCtD
Rizatriptan—Vision blurred—Methotrexate—hematologic cancer	2.69e-05	0.000116	CcSEcCtD
Rizatriptan—Mental disorder—Epirubicin—hematologic cancer	2.68e-05	0.000115	CcSEcCtD
Rizatriptan—Rash—Cisplatin—hematologic cancer	2.67e-05	0.000115	CcSEcCtD
Rizatriptan—Dermatitis—Cisplatin—hematologic cancer	2.67e-05	0.000115	CcSEcCtD
Rizatriptan—Erythema—Epirubicin—hematologic cancer	2.67e-05	0.000115	CcSEcCtD
Rizatriptan—Diarrhoea—Etoposide—hematologic cancer	2.66e-05	0.000114	CcSEcCtD
Rizatriptan—Anorexia—Prednisone—hematologic cancer	2.65e-05	0.000114	CcSEcCtD
Rizatriptan—Tinnitus—Doxorubicin—hematologic cancer	2.64e-05	0.000114	CcSEcCtD
Rizatriptan—Feeling abnormal—Dexamethasone—hematologic cancer	2.63e-05	0.000113	CcSEcCtD
Rizatriptan—Feeling abnormal—Betamethasone—hematologic cancer	2.63e-05	0.000113	CcSEcCtD
Rizatriptan—Flushing—Doxorubicin—hematologic cancer	2.63e-05	0.000113	CcSEcCtD
Rizatriptan—Flatulence—Epirubicin—hematologic cancer	2.63e-05	0.000113	CcSEcCtD
Rizatriptan—Tension—Epirubicin—hematologic cancer	2.62e-05	0.000113	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Dexamethasone—hematologic cancer	2.61e-05	0.000112	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Betamethasone—hematologic cancer	2.61e-05	0.000112	CcSEcCtD
Rizatriptan—Dysgeusia—Epirubicin—hematologic cancer	2.61e-05	0.000112	CcSEcCtD
Rizatriptan—Hypersensitivity—Triamcinolone—hematologic cancer	2.6e-05	0.000112	CcSEcCtD
Rizatriptan—Nervousness—Epirubicin—hematologic cancer	2.59e-05	0.000111	CcSEcCtD
Rizatriptan—Angiopathy—Doxorubicin—hematologic cancer	2.57e-05	0.000111	CcSEcCtD
Rizatriptan—Dizziness—Etoposide—hematologic cancer	2.57e-05	0.00011	CcSEcCtD
Rizatriptan—Muscle spasms—Epirubicin—hematologic cancer	2.56e-05	0.00011	CcSEcCtD
Rizatriptan—Vertigo—Methotrexate—hematologic cancer	2.56e-05	0.00011	CcSEcCtD
Rizatriptan—Chills—Doxorubicin—hematologic cancer	2.54e-05	0.000109	CcSEcCtD
Rizatriptan—Urticaria—Betamethasone—hematologic cancer	2.54e-05	0.000109	CcSEcCtD
Rizatriptan—Urticaria—Dexamethasone—hematologic cancer	2.54e-05	0.000109	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Prednisone—hematologic cancer	2.54e-05	0.000109	CcSEcCtD
Rizatriptan—Dizziness—Prednisolone—hematologic cancer	2.53e-05	0.000109	CcSEcCtD
Rizatriptan—Arrhythmia—Doxorubicin—hematologic cancer	2.53e-05	0.000109	CcSEcCtD
Rizatriptan—Asthenia—Triamcinolone—hematologic cancer	2.53e-05	0.000109	CcSEcCtD
Rizatriptan—Abdominal pain—Dexamethasone—hematologic cancer	2.53e-05	0.000109	CcSEcCtD
Rizatriptan—Abdominal pain—Betamethasone—hematologic cancer	2.53e-05	0.000109	CcSEcCtD
Rizatriptan—Body temperature increased—Dexamethasone—hematologic cancer	2.53e-05	0.000109	CcSEcCtD
Rizatriptan—Body temperature increased—Betamethasone—hematologic cancer	2.53e-05	0.000109	CcSEcCtD
Rizatriptan—Nausea—Cisplatin—hematologic cancer	2.52e-05	0.000108	CcSEcCtD
Rizatriptan—Insomnia—Prednisone—hematologic cancer	2.52e-05	0.000108	CcSEcCtD
Rizatriptan—Vision blurred—Epirubicin—hematologic cancer	2.51e-05	0.000108	CcSEcCtD
Rizatriptan—Paraesthesia—Prednisone—hematologic cancer	2.5e-05	0.000107	CcSEcCtD
Rizatriptan—Pruritus—Triamcinolone—hematologic cancer	2.49e-05	0.000107	CcSEcCtD
Rizatriptan—Cough—Methotrexate—hematologic cancer	2.49e-05	0.000107	CcSEcCtD
Rizatriptan—Mental disorder—Doxorubicin—hematologic cancer	2.48e-05	0.000107	CcSEcCtD
Rizatriptan—Convulsion—Methotrexate—hematologic cancer	2.47e-05	0.000106	CcSEcCtD
Rizatriptan—Vomiting—Etoposide—hematologic cancer	2.47e-05	0.000106	CcSEcCtD
Rizatriptan—Erythema—Doxorubicin—hematologic cancer	2.47e-05	0.000106	CcSEcCtD
Rizatriptan—Agitation—Epirubicin—hematologic cancer	2.45e-05	0.000105	CcSEcCtD
Rizatriptan—Dyspepsia—Prednisone—hematologic cancer	2.45e-05	0.000105	CcSEcCtD
Rizatriptan—Rash—Etoposide—hematologic cancer	2.45e-05	0.000105	CcSEcCtD
Rizatriptan—Dermatitis—Etoposide—hematologic cancer	2.45e-05	0.000105	CcSEcCtD
Rizatriptan—Headache—Etoposide—hematologic cancer	2.43e-05	0.000105	CcSEcCtD
Rizatriptan—Flatulence—Doxorubicin—hematologic cancer	2.43e-05	0.000105	CcSEcCtD
Rizatriptan—Arthralgia—Methotrexate—hematologic cancer	2.43e-05	0.000104	CcSEcCtD
Rizatriptan—Myalgia—Methotrexate—hematologic cancer	2.43e-05	0.000104	CcSEcCtD
Rizatriptan—Chest pain—Methotrexate—hematologic cancer	2.43e-05	0.000104	CcSEcCtD
Rizatriptan—Tension—Doxorubicin—hematologic cancer	2.42e-05	0.000104	CcSEcCtD
Rizatriptan—Decreased appetite—Prednisone—hematologic cancer	2.42e-05	0.000104	CcSEcCtD
Rizatriptan—Dysgeusia—Doxorubicin—hematologic cancer	2.42e-05	0.000104	CcSEcCtD
Rizatriptan—Rash—Prednisolone—hematologic cancer	2.42e-05	0.000104	CcSEcCtD
Rizatriptan—Dermatitis—Prednisolone—hematologic cancer	2.41e-05	0.000104	CcSEcCtD
Rizatriptan—Fatigue—Prednisone—hematologic cancer	2.4e-05	0.000103	CcSEcCtD
Rizatriptan—Headache—Prednisolone—hematologic cancer	2.4e-05	0.000103	CcSEcCtD
Rizatriptan—Discomfort—Methotrexate—hematologic cancer	2.4e-05	0.000103	CcSEcCtD
Rizatriptan—Nervousness—Doxorubicin—hematologic cancer	2.4e-05	0.000103	CcSEcCtD
Rizatriptan—Vertigo—Epirubicin—hematologic cancer	2.4e-05	0.000103	CcSEcCtD
Rizatriptan—Syncope—Epirubicin—hematologic cancer	2.39e-05	0.000103	CcSEcCtD
Rizatriptan—Constipation—Prednisone—hematologic cancer	2.38e-05	0.000102	CcSEcCtD
Rizatriptan—Muscle spasms—Doxorubicin—hematologic cancer	2.37e-05	0.000102	CcSEcCtD
Rizatriptan—Palpitations—Epirubicin—hematologic cancer	2.36e-05	0.000101	CcSEcCtD
Rizatriptan—Confusional state—Methotrexate—hematologic cancer	2.35e-05	0.000101	CcSEcCtD
Rizatriptan—Loss of consciousness—Epirubicin—hematologic cancer	2.34e-05	0.000101	CcSEcCtD
Rizatriptan—Dizziness—Triamcinolone—hematologic cancer	2.33e-05	0.0001	CcSEcCtD
Rizatriptan—Cough—Epirubicin—hematologic cancer	2.33e-05	0.0001	CcSEcCtD
Rizatriptan—Anaphylactic shock—Methotrexate—hematologic cancer	2.33e-05	0.0001	CcSEcCtD
Rizatriptan—Vision blurred—Doxorubicin—hematologic cancer	2.33e-05	0.0001	CcSEcCtD
Rizatriptan—Convulsion—Epirubicin—hematologic cancer	2.31e-05	9.94e-05	CcSEcCtD
Rizatriptan—Nausea—Etoposide—hematologic cancer	2.31e-05	9.92e-05	CcSEcCtD
Rizatriptan—Hypertension—Epirubicin—hematologic cancer	2.3e-05	9.9e-05	CcSEcCtD
Rizatriptan—Feeling abnormal—Prednisone—hematologic cancer	2.29e-05	9.86e-05	CcSEcCtD
Rizatriptan—Asthenia—Dexamethasone—hematologic cancer	2.29e-05	9.86e-05	CcSEcCtD
Rizatriptan—Asthenia—Betamethasone—hematologic cancer	2.29e-05	9.86e-05	CcSEcCtD
Rizatriptan—Nervous system disorder—Methotrexate—hematologic cancer	2.28e-05	9.81e-05	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Prednisone—hematologic cancer	2.28e-05	9.79e-05	CcSEcCtD
Rizatriptan—Nausea—Prednisolone—hematologic cancer	2.28e-05	9.79e-05	CcSEcCtD
Rizatriptan—Chest pain—Epirubicin—hematologic cancer	2.27e-05	9.77e-05	CcSEcCtD
Rizatriptan—Arthralgia—Epirubicin—hematologic cancer	2.27e-05	9.77e-05	CcSEcCtD
Rizatriptan—Myalgia—Epirubicin—hematologic cancer	2.27e-05	9.77e-05	CcSEcCtD
Rizatriptan—Agitation—Doxorubicin—hematologic cancer	2.27e-05	9.75e-05	CcSEcCtD
Rizatriptan—Anxiety—Epirubicin—hematologic cancer	2.26e-05	9.73e-05	CcSEcCtD
Rizatriptan—Pruritus—Dexamethasone—hematologic cancer	2.26e-05	9.73e-05	CcSEcCtD
Rizatriptan—Pruritus—Betamethasone—hematologic cancer	2.26e-05	9.73e-05	CcSEcCtD
Rizatriptan—Hyperhidrosis—Methotrexate—hematologic cancer	2.25e-05	9.67e-05	CcSEcCtD
Rizatriptan—Discomfort—Epirubicin—hematologic cancer	2.24e-05	9.65e-05	CcSEcCtD
Rizatriptan—Vomiting—Triamcinolone—hematologic cancer	2.24e-05	9.63e-05	CcSEcCtD
Rizatriptan—Rash—Triamcinolone—hematologic cancer	2.22e-05	9.55e-05	CcSEcCtD
Rizatriptan—Dry mouth—Epirubicin—hematologic cancer	2.22e-05	9.55e-05	CcSEcCtD
Rizatriptan—Dermatitis—Triamcinolone—hematologic cancer	2.22e-05	9.54e-05	CcSEcCtD
Rizatriptan—Vertigo—Doxorubicin—hematologic cancer	2.22e-05	9.54e-05	CcSEcCtD
Rizatriptan—Anorexia—Methotrexate—hematologic cancer	2.22e-05	9.54e-05	CcSEcCtD
Rizatriptan—Syncope—Doxorubicin—hematologic cancer	2.21e-05	9.52e-05	CcSEcCtD
Rizatriptan—Urticaria—Prednisone—hematologic cancer	2.21e-05	9.51e-05	CcSEcCtD
Rizatriptan—Headache—Triamcinolone—hematologic cancer	2.21e-05	9.49e-05	CcSEcCtD
Rizatriptan—Abdominal pain—Prednisone—hematologic cancer	2.2e-05	9.46e-05	CcSEcCtD
Rizatriptan—Body temperature increased—Prednisone—hematologic cancer	2.2e-05	9.46e-05	CcSEcCtD
Rizatriptan—Confusional state—Epirubicin—hematologic cancer	2.2e-05	9.44e-05	CcSEcCtD
Rizatriptan—Diarrhoea—Dexamethasone—hematologic cancer	2.19e-05	9.41e-05	CcSEcCtD
Rizatriptan—Diarrhoea—Betamethasone—hematologic cancer	2.19e-05	9.41e-05	CcSEcCtD
Rizatriptan—Palpitations—Doxorubicin—hematologic cancer	2.18e-05	9.38e-05	CcSEcCtD
Rizatriptan—Oedema—Epirubicin—hematologic cancer	2.18e-05	9.36e-05	CcSEcCtD
Rizatriptan—Anaphylactic shock—Epirubicin—hematologic cancer	2.18e-05	9.36e-05	CcSEcCtD
Rizatriptan—Loss of consciousness—Doxorubicin—hematologic cancer	2.17e-05	9.33e-05	CcSEcCtD
Rizatriptan—Cough—Doxorubicin—hematologic cancer	2.15e-05	9.26e-05	CcSEcCtD
Rizatriptan—Shock—Epirubicin—hematologic cancer	2.14e-05	9.21e-05	CcSEcCtD
Rizatriptan—Convulsion—Doxorubicin—hematologic cancer	2.14e-05	9.2e-05	CcSEcCtD
Rizatriptan—Nervous system disorder—Epirubicin—hematologic cancer	2.13e-05	9.18e-05	CcSEcCtD
Rizatriptan—Hypertension—Doxorubicin—hematologic cancer	2.13e-05	9.16e-05	CcSEcCtD
Rizatriptan—Tachycardia—Epirubicin—hematologic cancer	2.12e-05	9.14e-05	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Methotrexate—hematologic cancer	2.12e-05	9.11e-05	CcSEcCtD
Rizatriptan—Dizziness—Dexamethasone—hematologic cancer	2.11e-05	9.09e-05	CcSEcCtD
Rizatriptan—Dizziness—Betamethasone—hematologic cancer	2.11e-05	9.09e-05	CcSEcCtD
Rizatriptan—Hyperhidrosis—Epirubicin—hematologic cancer	2.1e-05	9.05e-05	CcSEcCtD
Rizatriptan—Insomnia—Methotrexate—hematologic cancer	2.1e-05	9.05e-05	CcSEcCtD
Rizatriptan—Arthralgia—Doxorubicin—hematologic cancer	2.1e-05	9.04e-05	CcSEcCtD
Rizatriptan—Chest pain—Doxorubicin—hematologic cancer	2.1e-05	9.04e-05	CcSEcCtD
Rizatriptan—Myalgia—Doxorubicin—hematologic cancer	2.1e-05	9.04e-05	CcSEcCtD
Rizatriptan—Anxiety—Doxorubicin—hematologic cancer	2.09e-05	9.01e-05	CcSEcCtD
Rizatriptan—Nausea—Triamcinolone—hematologic cancer	2.09e-05	9e-05	CcSEcCtD
Rizatriptan—Paraesthesia—Methotrexate—hematologic cancer	2.09e-05	8.98e-05	CcSEcCtD
Rizatriptan—Discomfort—Doxorubicin—hematologic cancer	2.08e-05	8.93e-05	CcSEcCtD
Rizatriptan—Anorexia—Epirubicin—hematologic cancer	2.08e-05	8.92e-05	CcSEcCtD
Rizatriptan—Dyspnoea—Methotrexate—hematologic cancer	2.07e-05	8.92e-05	CcSEcCtD
Rizatriptan—Somnolence—Methotrexate—hematologic cancer	2.07e-05	8.89e-05	CcSEcCtD
Rizatriptan—Dry mouth—Doxorubicin—hematologic cancer	2.05e-05	8.84e-05	CcSEcCtD
Rizatriptan—Hypersensitivity—Prednisone—hematologic cancer	2.05e-05	8.82e-05	CcSEcCtD
Rizatriptan—Dyspepsia—Methotrexate—hematologic cancer	2.05e-05	8.81e-05	CcSEcCtD
Rizatriptan—Vomiting—Dexamethasone—hematologic cancer	2.03e-05	8.74e-05	CcSEcCtD
Rizatriptan—Vomiting—Betamethasone—hematologic cancer	2.03e-05	8.74e-05	CcSEcCtD
Rizatriptan—Confusional state—Doxorubicin—hematologic cancer	2.03e-05	8.73e-05	CcSEcCtD
Rizatriptan—Decreased appetite—Methotrexate—hematologic cancer	2.02e-05	8.7e-05	CcSEcCtD
Rizatriptan—Rash—Dexamethasone—hematologic cancer	2.02e-05	8.67e-05	CcSEcCtD
Rizatriptan—Rash—Betamethasone—hematologic cancer	2.02e-05	8.67e-05	CcSEcCtD
Rizatriptan—Anaphylactic shock—Doxorubicin—hematologic cancer	2.01e-05	8.66e-05	CcSEcCtD
Rizatriptan—Oedema—Doxorubicin—hematologic cancer	2.01e-05	8.66e-05	CcSEcCtD
Rizatriptan—Dermatitis—Dexamethasone—hematologic cancer	2.01e-05	8.66e-05	CcSEcCtD
Rizatriptan—Dermatitis—Betamethasone—hematologic cancer	2.01e-05	8.66e-05	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Methotrexate—hematologic cancer	2.01e-05	8.64e-05	CcSEcCtD
Rizatriptan—Fatigue—Methotrexate—hematologic cancer	2.01e-05	8.63e-05	CcSEcCtD
Rizatriptan—Headache—Dexamethasone—hematologic cancer	2e-05	8.61e-05	CcSEcCtD
Rizatriptan—Headache—Betamethasone—hematologic cancer	2e-05	8.61e-05	CcSEcCtD
Rizatriptan—Asthenia—Prednisone—hematologic cancer	2e-05	8.59e-05	CcSEcCtD
Rizatriptan—Pain—Methotrexate—hematologic cancer	1.99e-05	8.56e-05	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.98e-05	8.53e-05	CcSEcCtD
Rizatriptan—Shock—Doxorubicin—hematologic cancer	1.98e-05	8.52e-05	CcSEcCtD
Rizatriptan—Nervous system disorder—Doxorubicin—hematologic cancer	1.98e-05	8.5e-05	CcSEcCtD
Rizatriptan—Pruritus—Prednisone—hematologic cancer	1.97e-05	8.47e-05	CcSEcCtD
Rizatriptan—Insomnia—Epirubicin—hematologic cancer	1.97e-05	8.47e-05	CcSEcCtD
Rizatriptan—Tachycardia—Doxorubicin—hematologic cancer	1.97e-05	8.45e-05	CcSEcCtD
Rizatriptan—Paraesthesia—Epirubicin—hematologic cancer	1.95e-05	8.41e-05	CcSEcCtD
Rizatriptan—Hyperhidrosis—Doxorubicin—hematologic cancer	1.95e-05	8.37e-05	CcSEcCtD
Rizatriptan—Dyspnoea—Epirubicin—hematologic cancer	1.94e-05	8.35e-05	CcSEcCtD
Rizatriptan—Somnolence—Epirubicin—hematologic cancer	1.94e-05	8.32e-05	CcSEcCtD
Rizatriptan—Anorexia—Doxorubicin—hematologic cancer	1.92e-05	8.26e-05	CcSEcCtD
Rizatriptan—Feeling abnormal—Methotrexate—hematologic cancer	1.92e-05	8.24e-05	CcSEcCtD
Rizatriptan—Dyspepsia—Epirubicin—hematologic cancer	1.92e-05	8.24e-05	CcSEcCtD
Rizatriptan—Diarrhoea—Prednisone—hematologic cancer	1.9e-05	8.19e-05	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Methotrexate—hematologic cancer	1.9e-05	8.18e-05	CcSEcCtD
Rizatriptan—Nausea—Dexamethasone—hematologic cancer	1.9e-05	8.16e-05	CcSEcCtD
Rizatriptan—Nausea—Betamethasone—hematologic cancer	1.9e-05	8.16e-05	CcSEcCtD
Rizatriptan—Decreased appetite—Epirubicin—hematologic cancer	1.89e-05	8.14e-05	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.88e-05	8.08e-05	CcSEcCtD
Rizatriptan—Fatigue—Epirubicin—hematologic cancer	1.88e-05	8.07e-05	CcSEcCtD
Rizatriptan—Constipation—Epirubicin—hematologic cancer	1.86e-05	8.01e-05	CcSEcCtD
Rizatriptan—Pain—Epirubicin—hematologic cancer	1.86e-05	8.01e-05	CcSEcCtD
Rizatriptan—Urticaria—Methotrexate—hematologic cancer	1.85e-05	7.95e-05	CcSEcCtD
Rizatriptan—Dizziness—Prednisone—hematologic cancer	1.84e-05	7.92e-05	CcSEcCtD
Rizatriptan—Abdominal pain—Methotrexate—hematologic cancer	1.84e-05	7.91e-05	CcSEcCtD
Rizatriptan—Body temperature increased—Methotrexate—hematologic cancer	1.84e-05	7.91e-05	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.84e-05	7.89e-05	CcSEcCtD
Rizatriptan—Insomnia—Doxorubicin—hematologic cancer	1.82e-05	7.84e-05	CcSEcCtD
Rizatriptan—Paraesthesia—Doxorubicin—hematologic cancer	1.81e-05	7.78e-05	CcSEcCtD
Rizatriptan—Dyspnoea—Doxorubicin—hematologic cancer	1.8e-05	7.72e-05	CcSEcCtD
Rizatriptan—Feeling abnormal—Epirubicin—hematologic cancer	1.79e-05	7.72e-05	CcSEcCtD
Rizatriptan—Somnolence—Doxorubicin—hematologic cancer	1.79e-05	7.7e-05	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Epirubicin—hematologic cancer	1.78e-05	7.66e-05	CcSEcCtD
Rizatriptan—Dyspepsia—Doxorubicin—hematologic cancer	1.77e-05	7.63e-05	CcSEcCtD
Rizatriptan—Vomiting—Prednisone—hematologic cancer	1.77e-05	7.61e-05	CcSEcCtD
Rizatriptan—Rash—Prednisone—hematologic cancer	1.76e-05	7.55e-05	CcSEcCtD
Rizatriptan—Dermatitis—Prednisone—hematologic cancer	1.75e-05	7.54e-05	CcSEcCtD
Rizatriptan—Decreased appetite—Doxorubicin—hematologic cancer	1.75e-05	7.53e-05	CcSEcCtD
Rizatriptan—Headache—Prednisone—hematologic cancer	1.74e-05	7.5e-05	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.74e-05	7.48e-05	CcSEcCtD
Rizatriptan—Fatigue—Doxorubicin—hematologic cancer	1.74e-05	7.47e-05	CcSEcCtD
Rizatriptan—Urticaria—Epirubicin—hematologic cancer	1.73e-05	7.44e-05	CcSEcCtD
Rizatriptan—Pain—Doxorubicin—hematologic cancer	1.72e-05	7.41e-05	CcSEcCtD
Rizatriptan—Constipation—Doxorubicin—hematologic cancer	1.72e-05	7.41e-05	CcSEcCtD
Rizatriptan—Abdominal pain—Epirubicin—hematologic cancer	1.72e-05	7.4e-05	CcSEcCtD
Rizatriptan—Body temperature increased—Epirubicin—hematologic cancer	1.72e-05	7.4e-05	CcSEcCtD
Rizatriptan—Hypersensitivity—Methotrexate—hematologic cancer	1.71e-05	7.37e-05	CcSEcCtD
Rizatriptan—Asthenia—Methotrexate—hematologic cancer	1.67e-05	7.18e-05	CcSEcCtD
Rizatriptan—Feeling abnormal—Doxorubicin—hematologic cancer	1.66e-05	7.14e-05	CcSEcCtD
Rizatriptan—Nausea—Prednisone—hematologic cancer	1.65e-05	7.11e-05	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.65e-05	7.08e-05	CcSEcCtD
Rizatriptan—Pruritus—Methotrexate—hematologic cancer	1.65e-05	7.08e-05	CcSEcCtD
Rizatriptan—Hypersensitivity—Epirubicin—hematologic cancer	1.6e-05	6.9e-05	CcSEcCtD
Rizatriptan—Urticaria—Doxorubicin—hematologic cancer	1.6e-05	6.88e-05	CcSEcCtD
Rizatriptan—Abdominal pain—Doxorubicin—hematologic cancer	1.59e-05	6.85e-05	CcSEcCtD
Rizatriptan—Body temperature increased—Doxorubicin—hematologic cancer	1.59e-05	6.85e-05	CcSEcCtD
Rizatriptan—Diarrhoea—Methotrexate—hematologic cancer	1.59e-05	6.85e-05	CcSEcCtD
Rizatriptan—Asthenia—Epirubicin—hematologic cancer	1.56e-05	6.72e-05	CcSEcCtD
Rizatriptan—Pruritus—Epirubicin—hematologic cancer	1.54e-05	6.62e-05	CcSEcCtD
Rizatriptan—Dizziness—Methotrexate—hematologic cancer	1.54e-05	6.62e-05	CcSEcCtD
Rizatriptan—Diarrhoea—Epirubicin—hematologic cancer	1.49e-05	6.41e-05	CcSEcCtD
Rizatriptan—Hypersensitivity—Doxorubicin—hematologic cancer	1.48e-05	6.38e-05	CcSEcCtD
Rizatriptan—Vomiting—Methotrexate—hematologic cancer	1.48e-05	6.36e-05	CcSEcCtD
Rizatriptan—Rash—Methotrexate—hematologic cancer	1.47e-05	6.31e-05	CcSEcCtD
Rizatriptan—Dermatitis—Methotrexate—hematologic cancer	1.47e-05	6.3e-05	CcSEcCtD
Rizatriptan—Headache—Methotrexate—hematologic cancer	1.46e-05	6.27e-05	CcSEcCtD
Rizatriptan—Asthenia—Doxorubicin—hematologic cancer	1.45e-05	6.22e-05	CcSEcCtD
Rizatriptan—Dizziness—Epirubicin—hematologic cancer	1.44e-05	6.19e-05	CcSEcCtD
Rizatriptan—Pruritus—Doxorubicin—hematologic cancer	1.43e-05	6.13e-05	CcSEcCtD
Rizatriptan—Vomiting—Epirubicin—hematologic cancer	1.38e-05	5.95e-05	CcSEcCtD
Rizatriptan—Nausea—Methotrexate—hematologic cancer	1.38e-05	5.94e-05	CcSEcCtD
Rizatriptan—Diarrhoea—Doxorubicin—hematologic cancer	1.38e-05	5.93e-05	CcSEcCtD
Rizatriptan—Rash—Epirubicin—hematologic cancer	1.37e-05	5.9e-05	CcSEcCtD
Rizatriptan—Dermatitis—Epirubicin—hematologic cancer	1.37e-05	5.9e-05	CcSEcCtD
Rizatriptan—Headache—Epirubicin—hematologic cancer	1.36e-05	5.87e-05	CcSEcCtD
Rizatriptan—Dizziness—Doxorubicin—hematologic cancer	1.33e-05	5.73e-05	CcSEcCtD
Rizatriptan—Nausea—Epirubicin—hematologic cancer	1.29e-05	5.56e-05	CcSEcCtD
Rizatriptan—Vomiting—Doxorubicin—hematologic cancer	1.28e-05	5.51e-05	CcSEcCtD
Rizatriptan—Rash—Doxorubicin—hematologic cancer	1.27e-05	5.46e-05	CcSEcCtD
Rizatriptan—Dermatitis—Doxorubicin—hematologic cancer	1.27e-05	5.46e-05	CcSEcCtD
Rizatriptan—Headache—Doxorubicin—hematologic cancer	1.26e-05	5.43e-05	CcSEcCtD
Rizatriptan—Nausea—Doxorubicin—hematologic cancer	1.2e-05	5.15e-05	CcSEcCtD
Rizatriptan—CYP1A2—Metabolism—TXN—hematologic cancer	6.77e-06	0.000133	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PIK3CG—hematologic cancer	6.74e-06	0.000132	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—PIK3R1—hematologic cancer	6.73e-06	0.000132	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—FN1—hematologic cancer	6.71e-06	0.000132	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—CDKN1A—hematologic cancer	6.66e-06	0.000131	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—ESR1—hematologic cancer	6.65e-06	0.000131	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—PTEN—hematologic cancer	6.65e-06	0.000131	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—SPHK1—hematologic cancer	6.63e-06	0.00013	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—NFKBIA—hematologic cancer	6.63e-06	0.00013	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—BAD—hematologic cancer	6.63e-06	0.00013	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CD86—hematologic cancer	6.58e-06	0.000129	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—FN1—hematologic cancer	6.57e-06	0.000129	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—NOTCH1—hematologic cancer	6.56e-06	0.000129	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—JAK2—hematologic cancer	6.54e-06	0.000128	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—MAPK8—hematologic cancer	6.5e-06	0.000128	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—BAD—hematologic cancer	6.49e-06	0.000127	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—NFKBIA—hematologic cancer	6.49e-06	0.000127	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—HES1—hematologic cancer	6.49e-06	0.000127	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—AKT1—hematologic cancer	6.48e-06	0.000127	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—NCOR1—hematologic cancer	6.45e-06	0.000127	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CD80—hematologic cancer	6.43e-06	0.000126	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—NOTCH1—hematologic cancer	6.43e-06	0.000126	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PIK3CG—hematologic cancer	6.42e-06	0.000126	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—KIT—hematologic cancer	6.42e-06	0.000126	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—NRAS—hematologic cancer	6.42e-06	0.000126	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—FGF1—hematologic cancer	6.38e-06	0.000125	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CSF2—hematologic cancer	6.38e-06	0.000125	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—UGT1A1—hematologic cancer	6.37e-06	0.000125	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—EP300—hematologic cancer	6.34e-06	0.000125	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PTPN11—hematologic cancer	6.31e-06	0.000124	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CD80—hematologic cancer	6.3e-06	0.000124	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PIK3CG—hematologic cancer	6.29e-06	0.000123	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—KIT—hematologic cancer	6.29e-06	0.000123	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—NRAS—hematologic cancer	6.29e-06	0.000123	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—FOXO1—hematologic cancer	6.28e-06	0.000123	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—IL2—hematologic cancer	6.28e-06	0.000123	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PDGFRB—hematologic cancer	6.27e-06	0.000123	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—CREBBP—hematologic cancer	6.25e-06	0.000123	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—PIK3CB—hematologic cancer	6.21e-06	0.000122	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—SLC22A1—hematologic cancer	6.2e-06	0.000122	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CRABP1—hematologic cancer	6.2e-06	0.000122	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PTPN11—hematologic cancer	6.18e-06	0.000121	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PDGFRA—hematologic cancer	6.18e-06	0.000121	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—SRC—hematologic cancer	6.16e-06	0.000121	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—JAK1—hematologic cancer	6.15e-06	0.000121	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PRKCG—hematologic cancer	6.15e-06	0.000121	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—MAPK3—hematologic cancer	6.15e-06	0.000121	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CREB1—hematologic cancer	6.11e-06	0.00012	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ALOX5—hematologic cancer	6.04e-06	0.000119	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—BRAF—hematologic cancer	6.03e-06	0.000119	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—MAPK3—hematologic cancer	6.02e-06	0.000118	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—VEGFA—hematologic cancer	6e-06	0.000118	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CREB1—hematologic cancer	5.98e-06	0.000118	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CCL2—hematologic cancer	5.98e-06	0.000117	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—IL6R—hematologic cancer	5.96e-06	0.000117	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CREBBP—hematologic cancer	5.95e-06	0.000117	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—STAT3—hematologic cancer	5.94e-06	0.000117	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—NRAS—hematologic cancer	5.93e-06	0.000116	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PIK3CD—hematologic cancer	5.92e-06	0.000116	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—BRAF—hematologic cancer	5.91e-06	0.000116	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CCL2—hematologic cancer	5.85e-06	0.000115	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—NUP98—hematologic cancer	5.85e-06	0.000115	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—ALB—hematologic cancer	5.85e-06	0.000115	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—IL6R—hematologic cancer	5.84e-06	0.000115	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CREBBP—hematologic cancer	5.83e-06	0.000114	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—IL2RA—hematologic cancer	5.75e-06	0.000113	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—IL2—hematologic cancer	5.7e-06	0.000112	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—TERT—hematologic cancer	5.68e-06	0.000112	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—MAP2K1—hematologic cancer	5.68e-06	0.000112	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—MAPK3—hematologic cancer	5.68e-06	0.000112	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ADCY7—hematologic cancer	5.68e-06	0.000112	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—NCOA3—hematologic cancer	5.68e-06	0.000112	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PIK3CD—hematologic cancer	5.64e-06	0.000111	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—NUP214—hematologic cancer	5.64e-06	0.000111	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PIK3R1—hematologic cancer	5.59e-06	0.00011	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—PIK3CA—hematologic cancer	5.59e-06	0.00011	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	5.58e-06	0.00011	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—MAP2K1—hematologic cancer	5.56e-06	0.000109	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PDGFB—hematologic cancer	5.55e-06	0.000109	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PIK3CD—hematologic cancer	5.53e-06	0.000109	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—KRAS—hematologic cancer	5.52e-06	0.000109	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—MYC—hematologic cancer	5.52e-06	0.000108	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—MTR—hematologic cancer	5.52e-06	0.000108	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ABCG2—hematologic cancer	5.52e-06	0.000108	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—TGFB1—hematologic cancer	5.51e-06	0.000108	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—PIK3CA—hematologic cancer	5.47e-06	0.000108	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—TSC2—hematologic cancer	5.42e-06	0.000106	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ENO2—hematologic cancer	5.42e-06	0.000106	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—KRAS—hematologic cancer	5.41e-06	0.000106	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—FGF2—hematologic cancer	5.4e-06	0.000106	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PIK3R1—hematologic cancer	5.33e-06	0.000105	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—FGF2—hematologic cancer	5.29e-06	0.000104	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GSTT1—hematologic cancer	5.25e-06	0.000103	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PIK3R1—hematologic cancer	5.22e-06	0.000102	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—FGFR3—hematologic cancer	5.22e-06	0.000102	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—JAK2—hematologic cancer	5.18e-06	0.000102	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	5.17e-06	0.000102	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—MAPK14—hematologic cancer	5.16e-06	0.000101	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PIK3CB—hematologic cancer	5.16e-06	0.000101	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—SDC1—hematologic cancer	5.13e-06	0.000101	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—KRAS—hematologic cancer	5.1e-06	0.0001	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—PIK3CA—hematologic cancer	5.08e-06	9.97e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—JAK2—hematologic cancer	5.07e-06	9.96e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—ESR1—hematologic cancer	5.07e-06	9.95e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—MDM2—hematologic cancer	5.06e-06	9.93e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—FN1—hematologic cancer	5e-06	9.83e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—PIK3CA—hematologic cancer	4.97e-06	9.76e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—MDM2—hematologic cancer	4.95e-06	9.72e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—BAD—hematologic cancer	4.94e-06	9.71e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—NFKBIA—hematologic cancer	4.94e-06	9.71e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—MTOR—hematologic cancer	4.92e-06	9.66e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PIK3CB—hematologic cancer	4.92e-06	9.66e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.9e-06	9.63e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—NOTCH1—hematologic cancer	4.9e-06	9.62e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	4.84e-06	9.51e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PIK3CB—hematologic cancer	4.82e-06	9.46e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—MTOR—hematologic cancer	4.82e-06	9.46e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CD80—hematologic cancer	4.8e-06	9.42e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PIK3CG—hematologic cancer	4.79e-06	9.41e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—KIT—hematologic cancer	4.79e-06	9.41e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—NRAS—hematologic cancer	4.79e-06	9.41e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PTPN11—hematologic cancer	4.7e-06	9.24e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—HRAS—hematologic cancer	4.7e-06	9.22e-05	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—PIK3CA—hematologic cancer	4.69e-06	9.21e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	4.63e-06	9.1e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CDKN1B—hematologic cancer	4.62e-06	9.07e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—HRAS—hematologic cancer	4.6e-06	9.03e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—MAPK3—hematologic cancer	4.59e-06	9.01e-05	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—AKT1—hematologic cancer	4.57e-06	8.97e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CREB1—hematologic cancer	4.56e-06	8.95e-05	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—TP53—hematologic cancer	4.54e-06	8.91e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CASP3—hematologic cancer	4.52e-06	8.89e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CDKN1B—hematologic cancer	4.52e-06	8.88e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—IL2—hematologic cancer	4.52e-06	8.87e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—BRAF—hematologic cancer	4.5e-06	8.84e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—IL6—hematologic cancer	4.49e-06	8.83e-05	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—AKT1—hematologic cancer	4.47e-06	8.78e-05	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PTEN—hematologic cancer	4.46e-06	8.76e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CCL2—hematologic cancer	4.46e-06	8.76e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—IL6R—hematologic cancer	4.45e-06	8.73e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CREBBP—hematologic cancer	4.44e-06	8.72e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CASP3—hematologic cancer	4.43e-06	8.7e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—IL2—hematologic cancer	4.42e-06	8.69e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CCND1—hematologic cancer	4.4e-06	8.65e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—IL6—hematologic cancer	4.4e-06	8.65e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—JUN—hematologic cancer	4.39e-06	8.63e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—NQO1—hematologic cancer	4.37e-06	8.58e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CD44—hematologic cancer	4.37e-06	8.58e-05	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—HRAS—hematologic cancer	4.34e-06	8.52e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CCND1—hematologic cancer	4.31e-06	8.47e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—JUN—hematologic cancer	4.3e-06	8.45e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.27e-06	8.4e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CDKN1A—hematologic cancer	4.26e-06	8.37e-05	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—EP300—hematologic cancer	4.25e-06	8.36e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PTEN—hematologic cancer	4.25e-06	8.35e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—MAP2K1—hematologic cancer	4.24e-06	8.32e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PIK3CD—hematologic cancer	4.21e-06	8.27e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CDKN1A—hematologic cancer	4.17e-06	8.19e-05	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—PIK3CA—hematologic cancer	4.17e-06	8.19e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PTEN—hematologic cancer	4.16e-06	8.18e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—MAPK8—hematologic cancer	4.16e-06	8.17e-05	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—IL6—hematologic cancer	4.15e-06	8.16e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—AKT1—hematologic cancer	4.15e-06	8.15e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CYCS—hematologic cancer	4.13e-06	8.11e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—KRAS—hematologic cancer	4.12e-06	8.1e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	4.1e-06	8.06e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—MAPK8—hematologic cancer	4.07e-06	8e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—AKT1—hematologic cancer	4.06e-06	7.98e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—EP300—hematologic cancer	4.05e-06	7.96e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—FGF2—hematologic cancer	4.03e-06	7.92e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PIK3R1—hematologic cancer	3.97e-06	7.81e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—EP300—hematologic cancer	3.97e-06	7.8e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—SRC—hematologic cancer	3.94e-06	7.74e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—JAK2—hematologic cancer	3.86e-06	7.59e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—SRC—hematologic cancer	3.86e-06	7.58e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—VEGFA—hematologic cancer	3.84e-06	7.54e-05	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—AKT1—hematologic cancer	3.83e-06	7.52e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—STAT3—hematologic cancer	3.8e-06	7.47e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—NRAS—hematologic cancer	3.79e-06	7.45e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—PIK3CA—hematologic cancer	3.79e-06	7.44e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—MDM2—hematologic cancer	3.77e-06	7.41e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—VEGFA—hematologic cancer	3.76e-06	7.38e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—STAT3—hematologic cancer	3.72e-06	7.31e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—NRAS—hematologic cancer	3.71e-06	7.29e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.69e-06	7.26e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—MTOR—hematologic cancer	3.67e-06	7.21e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PIK3CB—hematologic cancer	3.67e-06	7.21e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GSTP1—hematologic cancer	3.64e-06	7.15e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—MAPK3—hematologic cancer	3.63e-06	7.13e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—MAPK3—hematologic cancer	3.56e-06	6.99e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—MYC—hematologic cancer	3.53e-06	6.94e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—TGFB1—hematologic cancer	3.52e-06	6.92e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.52e-06	6.92e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—HRAS—hematologic cancer	3.5e-06	6.88e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—MYC—hematologic cancer	3.46e-06	6.79e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—TGFB1—hematologic cancer	3.45e-06	6.78e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ABCB1—hematologic cancer	3.45e-06	6.77e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CDKN1B—hematologic cancer	3.44e-06	6.76e-05	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—AKT1—hematologic cancer	3.41e-06	6.69e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CASP3—hematologic cancer	3.37e-06	6.63e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—IL2—hematologic cancer	3.37e-06	6.62e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—IL6—hematologic cancer	3.35e-06	6.59e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GSTM1—hematologic cancer	3.35e-06	6.57e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—NCOR1—hematologic cancer	3.35e-06	6.57e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CCND1—hematologic cancer	3.28e-06	6.45e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—JUN—hematologic cancer	3.28e-06	6.44e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—KRAS—hematologic cancer	3.26e-06	6.41e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—KRAS—hematologic cancer	3.2e-06	6.28e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CDKN1A—hematologic cancer	3.18e-06	6.24e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PTEN—hematologic cancer	3.17e-06	6.23e-05	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PIK3CA—hematologic cancer	3.15e-06	6.18e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—MAPK8—hematologic cancer	3.1e-06	6.09e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—AKT1—hematologic cancer	3.09e-06	6.08e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—EP300—hematologic cancer	3.02e-06	5.94e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PIK3CA—hematologic cancer	3e-06	5.89e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—MTHFR—hematologic cancer	2.96e-06	5.81e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—SRC—hematologic cancer	2.94e-06	5.78e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PIK3CA—hematologic cancer	2.94e-06	5.77e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—TP53—hematologic cancer	2.9e-06	5.7e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—VEGFA—hematologic cancer	2.86e-06	5.63e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—TP53—hematologic cancer	2.84e-06	5.58e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—STAT3—hematologic cancer	2.84e-06	5.57e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—NRAS—hematologic cancer	2.83e-06	5.56e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—HRAS—hematologic cancer	2.77e-06	5.45e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—HRAS—hematologic cancer	2.72e-06	5.34e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—MAPK3—hematologic cancer	2.71e-06	5.32e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—IL6—hematologic cancer	2.66e-06	5.22e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—MYC—hematologic cancer	2.63e-06	5.18e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—TGFB1—hematologic cancer	2.63e-06	5.16e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.61e-06	5.12e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—IL6—hematologic cancer	2.6e-06	5.11e-05	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—AKT1—hematologic cancer	2.57e-06	5.05e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PIK3CG—hematologic cancer	2.48e-06	4.88e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—AKT1—hematologic cancer	2.45e-06	4.81e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—KRAS—hematologic cancer	2.43e-06	4.78e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—AKT1—hematologic cancer	2.4e-06	4.71e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CREBBP—hematologic cancer	2.3e-06	4.52e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PIK3CA—hematologic cancer	2.24e-06	4.39e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PIK3CD—hematologic cancer	2.18e-06	4.29e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—TP53—hematologic cancer	2.16e-06	4.25e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ALB—hematologic cancer	2.16e-06	4.24e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—HRAS—hematologic cancer	2.07e-06	4.06e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PIK3R1—hematologic cancer	2.06e-06	4.05e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—IL6—hematologic cancer	1.98e-06	3.89e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PIK3CB—hematologic cancer	1.9e-06	3.74e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—AKT1—hematologic cancer	1.83e-06	3.59e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PTEN—hematologic cancer	1.65e-06	3.23e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—EP300—hematologic cancer	1.57e-06	3.08e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PIK3CA—hematologic cancer	1.16e-06	2.28e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—AKT1—hematologic cancer	9.48e-07	1.86e-05	CbGpPWpGaD
